Welcome to our dedicated page for IMAX SEC filings (Ticker: IMAX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
IMAX Corporation filings document the formal records behind its entertainment-technology business, NYSE-listed common shares and reported operating results. Recent Form 8-K disclosures cover quarterly and annual financial results, global box office metrics, system installations and signings, material agreements and financing activity, including convertible senior notes.
Proxy materials describe board matters, executive compensation, equity awards and shareholder voting items. Other current reports address leadership-continuity and governance disclosures, while filings also identify the company as a Canadian corporation with operations reported through Content Solutions and Technology Products and Services.
IMAX CORP (IMAX) officer Mark Welton, President IMAX Global Theatres, reported selling 30,000 common shares on 2026-08-25 in a sale classified as a “Sale in open market or private transaction” at an average price of $54.4736 per share. After this transaction, he directly holds 143,216 common shares and has remaining balances of 53,272 restricted share units, as disclosed in the footnote. The Rule 10b5‑1 checkbox is not marked as an affirmative trading plan.
IMAX CORP (IMAX) insider Kenneth Ian Weissman, Deputy GC, Corporate Secretary & CCO, reported a sale of 8,000 common shares on 2026-08-25 in an open-market or private transaction at a reported price of $54.5367 per share. Following this transaction, he held 28,205 common shares directly. A related footnote states that his aggregate remaining restricted share units and common share balances after this transaction are 11,253 restricted share units and 28,205 common shares, respectively.
IMAX CORP (IMAX) reported that Chief Financial Officer & EVP Natasha Fernandes sold 20,000 common shares on 2026-08-24 in an open market or private transaction at a price of $54.6277 per share. After this sale, she holds 35,596 common shares directly, and, according to a footnote, her aggregate remaining balances are 32,764 restricted share units and 35,596 common shares.
IMAX CORP (IMAX) received a notice that officer Mark Welton intends to sell up to 30,000 shares of IMAX common stock under Rule 144. The shares relate to restricted stock vesting under a registered plan on 03/07/2026 and are to be sold through Morgan Stanley Smith Barney LLC.
IMAX CORP (IMAX) is the issuer for a planned resale of its common stock under Rule 144 by Kenneth Weissman. The notice covers a proposed sale of 8,000 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $436,293.60 and a proposed sale date of August 25, 2026 on the NYSE.
The 8,000 shares were acquired on March 7, 2025 as restricted stock vesting under a registered plan, from IMAX as issuer, with cash as the form of payment. This filing is a procedural notice of intent to sell and does not itself change IMAX’s capital structure or operations.
IMAX CORP (IMAX) reports that officer Natasha Fernandes has filed a notice of proposed sale under Rule 144. The filing covers 20,000 shares of IMAX common stock, with an aggregate market value of $1,092,554.00, expected to be sold through Morgan Stanley Smith Barney LLC on or after 08/24/2026. These shares relate to restricted stock vesting on 03/07/2026 under a registered plan, granted for services rendered.
IMAX CORP (IMAX) amended the employment agreement of Chief Legal Officer and Senior Executive Vice President Robert D. Lister. The third amendment extends his agreement’s term to December 31, 2029, with compensation and severance terms unchanged from prior disclosures.
The amendment clarifies equity treatment. If IMAX terminates Mr. Lister for cause or he resigns without Good Reason before December 31, 2029, all granted but unvested equity awards are cancelled without consideration. However, if he resigns after giving at least six months’ written notice, or if his employment ends after December 31, 2029 because IMAX does not offer to continue his employment on substantially similar terms, all unvested equity awards as of that date will, under the LTIP’s Service Factor provision, continue to vest on the original schedule, with PSUs remaining subject to their original performance conditions.
IMAX CORP (IMAX) reported an insider transaction by Pablo Calamera, CTO & EVP. On 2026-08-20, he completed an open-market sale of 15,000 common shares at a price of $52.4116 per share. Following this sale, he directly held 43,012 common shares, and his aggregate remaining outstanding restricted share units totaled 20,840.
IMAX Corporation (IMAX) is the issuer of common stock that Richard Gelfond, identified as an officer, plans to sell under Rule 144. A broker, Goldman Sachs & Co. LLC, has been designated to sell 100,000 shares of IMAX common stock, with an indicated aggregate value of $5,274,000. The filing also lists prior sales by Gelfond during the past three months and shows IMAX common shares outstanding of 54,842,114 as of August 20, 2026.
IMAX CORP (IMAX) reported insider transactions by Chief Executive Officer Richard L. Gelfond involving option exercises and share sales executed under a Rule 10b5-1 trading plan dated May 19, 2026. On August 18 and 19, 2026, he converted stock options into a total of 356,757 common shares at an exercise price of $31.90 per share and sold the converted shares in open-market transactions. He also sold an additional 100,000 common shares on August 20, 2026.
Following these transactions, Mr. Gelfond’s aggregate remaining holdings are disclosed as 975,654 stock options, 231,562 restricted share units, and 665,002 common shares.